by Eric Christianson | May 11, 2025 | Infectious Disease and Oncology Medication and Disease State Clinical Pearls
Azole antifungals play a central role in the treatment and prevention of fungal infections, offering coverage against yeasts, molds, and dimorphic fungi depending on the agent. Each drug in this class comes with its own specific spectrum and set of indications. In a...
by Eric Christianson | Apr 30, 2025 | Infectious Disease and Oncology Medication and Disease State Clinical Pearls
Azole antifungals are known for treating various types of yeast, molds, and dimorphic fungi, however, their safety profiles significantly vary, especially when it comes to hepatotoxicity, QT prolongation, and gastrointestinal (GI) effects. We will break down and...
by Eric Christianson | Jun 26, 2022 | Drug Interaction Case Studies and Education For Pharmacists
Noval oral anticoagulants (NOACs) are non-vitamin K antagonists that include apixaban (pharmacology podcast), dabigatran, rivaroxaban, and edoxaban. NOACs are highly predictable and are less likely to interact with other medications, making them more favorable than...
